,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,21.1,Anaemia,6,15940626
0,22.0,Alopecia,3,15940726
1,22.0,Trichorrhexis,3,15940726
2,22.0,Eye disorder,3,15940726
3,22.0,Hair texture abnormal,3,15940726
4,22.0,Skin discolouration,6,15940726
0,21.1,Malignant neoplasm progression,3,15940766
0,22.0,Neutropenia,1,15940769
1,22.0,Renal failure,3,15940769
2,22.0,Flatulence,3,15940769
3,22.0,Diarrhoea,3,15940769
0,21.1,Off label use,6,15940805
1,21.1,Body temperature increased,3,15940805
2,21.1,White blood cell count decreased,3,15940805
0,21.1,Retching,3,15940806
1,21.1,Death,5,15940806
2,21.1,Nausea,3,15940806
3,21.1,Pruritus,3,15940806
4,21.1,Blood pressure diastolic increased,1,15940806
5,21.1,Blood pressure increased,1,15940806
6,21.1,Weight decreased,3,15940806
7,21.1,Blood sodium decreased,6,15940806
8,21.1,Fatigue,6,15940806
0,21.1,Interstitial lung disease,5,15940807
1,21.1,Cough,6,15940807
2,21.1,Blood pressure decreased,6,15940807
3,21.1,Influenza,6,15940807
0,21.1,Pneumonia aspiration,5,15940814
1,21.1,Skin infection,2,15940814
2,21.1,Dermatitis,2,15940814
3,21.1,Rhabdomyolysis,2,15940814
4,21.1,Retroperitoneal haemorrhage,2,15940814
5,21.1,Mental status changes,2,15940814
6,21.1,Renal failure,2,15940814
7,21.1,Seizure,2,15940814
8,21.1,Haemorrhagic anaemia,2,15940814
0,21.1,Acute kidney injury,5,15940851
0,22.1,Alopecia,2,15940861
0,22.0,Alopecia,2,15940863
0,22.1,Psychological trauma,6,15940865
1,22.1,Alopecia,2,15940865
0,22.0,Alopecia,2,15940866
1,22.0,Psychological trauma,6,15940866
0,22.1,Alopecia,3,15940868
1,22.1,Psychological trauma,6,15940868
0,22.0,Psychological trauma,6,15940870
1,22.0,Alopecia,2,15940870
0,22.0,Alopecia,2,15940871
0,22.0,Psychological trauma,6,15940873
1,22.0,Alopecia,3,15940873
0,22.0,Alopecia,3,15940876
0,22.0,Eczema,1,15940880
1,22.0,Product colour issue,6,15940880
2,22.0,Urticaria,6,15940880
0,22.0,Pyrexia,6,15940917
1,22.0,Toxic skin eruption,6,15940917
2,22.0,Vomiting,6,15940917
3,22.0,Flushing,6,15940917
4,22.0,Nausea,6,15940917
5,22.0,Erythema,1,15940917
6,22.0,Product colour issue,6,15940917
0,22.0,Meningitis,2,15940928
1,22.0,Muscular weakness,6,15940928
0,21.1,Neoplasm progression,6,15940953
0,21.1,Malignant neoplasm progression,6,15940969
0,21.1,Acute myeloid leukaemia,5,15941036
0,21.1,Nasopharyngitis,1,15941084
0,21.1,Pleural effusion,6,15941339
1,21.1,Oxygen saturation decreased,6,15941339
2,21.1,Pyrexia,6,15941339
0,21.1,Therapeutic response unexpected,6,15941598
1,21.1,Product use in unapproved indication,6,15941598
2,21.1,Off label use,6,15941598
0,21.1,Faeces discoloured,,15941616
0,21.1,Injection site fibrosis,,15941631
1,21.1,Injection site pain,,15941631
2,21.1,Pain,,15941631
3,21.1,Impaired quality of life,,15941631
4,21.1,Discomfort,,15941631
5,21.1,Wrong technique in product usage process,,15941631
0,21.1,Injection site discomfort,,15941634
1,21.1,Product dosage form issue,,15941634
2,21.1,Wrong technique in product usage process,,15941634
3,21.1,Injection site pain,,15941634
4,21.1,Product complaint,,15941634
0,21.1,Disease progression,,15941649
0,22.0,Seizure,2,15941697
1,22.0,Psoriasis,2,15941697
0,21.1,Suicidal ideation,6,15941701
1,21.1,Oedema peripheral,6,15941701
2,21.1,Muscular weakness,6,15941701
0,21.1,Abdominal pain upper,,15941776
1,21.1,Vision blurred,,15941776
0,21.1,Pancytopenia,2,15941780
1,21.1,Platelet count decreased,2,15941780
0,22.0,Death,5,15941851
0,21.1,Prostatic specific antigen increased,6,15941870
1,21.1,Drug ineffective,6,15941870
0,22.1,Disease progression,6,15941882
1,22.1,Renal impairment,3,15941882
2,22.1,Back pain,2,15941882
3,22.1,Tinea infection,2,15941882
4,22.1,Fall,1,15941882
5,22.1,Diabetes mellitus,2,15941882
6,22.1,Skin disorder,3,15941882
7,22.1,Blood magnesium decreased,1,15941882
8,22.1,Dizziness,1,15941882
9,22.1,Ocular hyperaemia,3,15941882
10,22.1,Acne,2,15941882
11,22.1,Metastases to lymph nodes,6,15941882
12,22.1,Hypomagnesaemia,2,15941882
0,21.1,Vein collapse,1,15941891
1,21.1,Malignant neoplasm progression,1,15941891
2,21.1,Back pain,1,15941891
3,21.1,Dizziness,3,15941891
0,21.1,Pulmonary embolism,2,15941906
1,21.1,Venous thrombosis limb,1,15941906
0,22.0,Ileus,6,15941977
0,21.1,Ovarian cancer recurrent,6,15942013
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15942013
0,21.1,Hospitalisation,,15942033
0,21.1,Pulmonary embolism,1,15942124
0,21.1,Thrombolysis,1,15942125
1,21.1,Transient ischaemic attack,1,15942125
0,21.1,Squamous cell carcinoma,6,15942215
0,21.1,Paranoia,,15942241
1,21.1,Self esteem decreased,,15942241
2,21.1,Confusional state,,15942241
3,21.1,Anger,,15942241
4,21.1,Loss of personal independence in daily activities,,15942241
0,21.1,Bone marrow failure,5,15942263
0,22.0,Disease progression,6,15942276
1,22.0,Decreased appetite,6,15942276
2,22.0,Hypomagnesaemia,2,15942276
3,22.0,Paronychia,2,15942276
4,22.0,Colon cancer,6,15942276
5,22.0,Rash,6,15942276
6,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,15942276
7,22.0,Neuropathy peripheral,6,15942276
0,21.1,Rhabdomyolysis,1,15942277
0,21.1,Hypocalcaemia,6,15942294
1,21.1,Bone pain,6,15942294
2,21.1,Hypoaesthesia,6,15942294
0,21.1,Product use in unapproved indication,6,15942357
1,21.1,Death,5,15942357
0,22.0,Hypothyroidism,6,15942370
1,22.0,Hyponatraemia,6,15942370
2,22.0,Pneumonia aspiration,6,15942370
3,22.0,Hyperkalaemia,6,15942370
0,22.0,Product use in unapproved indication,6,15942429
1,22.0,Malignant neoplasm progression,6,15942429
0,21.1,Dyspnoea,3,15942438
1,21.1,Prostatic specific antigen increased,3,15942438
2,21.1,Oral herpes,3,15942438
3,21.1,Pulmonary thrombosis,3,15942438
4,21.1,Injury,6,15942438
5,21.1,Hypotension,3,15942438
6,21.1,Pleural effusion,3,15942438
7,21.1,Ulcer,3,15942438
8,21.1,Prostatic specific antigen increased,3,15942438
9,21.1,Urinary incontinence,3,15942438
10,21.1,Drug ineffective,6,15942438
11,21.1,Weight decreased,3,15942438
12,21.1,Haemoglobin decreased,3,15942438
13,21.1,Bone cancer,3,15942438
0,21.1,Neutropenic sepsis,2,15942488
0,21.1,Product use in unapproved indication,6,15942512
1,21.1,Pneumonia,6,15942512
0,22.0,Fatigue,3,15942534
1,22.0,Depression,6,15942534
2,22.0,Hot flush,6,15942534
0,21.1,Amylase increased,2,15942555
1,21.1,Lipase increased,2,15942555
0,21.1,Pulmonary embolism,1,15942673
0,21.1,Death,,15942674
0,21.1,Sepsis,1,15942805
1,21.1,Off label use,6,15942805
0,21.1,Death,5,15942810
0,22.1,Sepsis,1,15942818
1,22.1,Pleuritic pain,1,15942818
2,22.1,Off label use,6,15942818
0,21.1,Peripheral sensory neuropathy,4,15942838
1,21.1,Stomatitis,4,15942838
2,21.1,Diarrhoea,1,15942838
3,21.1,Dysgeusia,6,15942838
4,21.1,Transaminases abnormal,6,15942838
5,21.1,Arthralgia,6,15942838
6,21.1,Insomnia,1,15942838
7,21.1,Myalgia,6,15942838
8,21.1,Hepatic failure,3,15942838
9,21.1,Rhinitis,3,15942838
0,21.1,Peripheral embolism,3,15942851
0,22.0,Erythema,1,15942855
1,22.0,Skin exfoliation,1,15942855
2,22.0,Skin discolouration,1,15942855
3,22.0,Skin haemorrhage,1,15942855
0,21.1,Haematochezia,1,15942859
1,21.1,Sepsis,1,15942859
2,21.1,Gastrointestinal haemorrhage,6,15942859
3,21.1,Colorectal cancer,2,15942859
4,21.1,Off label use,6,15942859
0,21.1,Oxygen saturation decreased,1,15942875
1,21.1,Hyperhidrosis,1,15942875
2,21.1,Vertigo,1,15942875
3,21.1,Hypotension,1,15942875
0,21.1,Pain,3,15942878
1,21.1,Contraindicated product administered,6,15942878
2,21.1,Nausea,1,15942878
3,21.1,Anaemia,3,15942878
0,21.1,Malignant neoplasm progression,5,15942904
1,21.1,Hypopituitarism,1,15942904
0,21.1,Prostate cancer,5,15942944
0,21.1,Decreased appetite,6,15942952
1,21.1,Off label use,6,15942952
0,22.1,Contusion,3,15943098
1,22.1,Acidosis,5,15943098
2,22.1,Renal failure,5,15943098
3,22.1,Gastric ulcer,3,15943098
4,22.1,Loss of consciousness,5,15943098
5,22.1,Diabetic ketoacidosis,5,15943098
6,22.1,Hepatic congestion,3,15943098
7,22.1,Blister,3,15943098
8,22.1,Oedema peripheral,3,15943098
9,22.1,Nausea,5,15943098
10,22.1,Unresponsive to stimuli,5,15943098
11,22.1,Pulmonary oedema,3,15943098
12,22.1,Hypophagia,5,15943098
13,22.1,Renal tubular necrosis,5,15943098
14,22.1,Hepatic steatosis,3,15943098
15,22.1,Myocardial ischaemia,3,15943098
16,22.1,Pulmonary congestion,3,15943098
17,22.1,Malaise,5,15943098
18,22.1,Acute kidney injury,5,15943098
19,22.1,Rhabdomyolysis,5,15943098
20,22.1,Vomiting,5,15943098
21,22.1,Hypothermia,5,15943098
22,22.1,Choroid plexus papilloma,3,15943098
23,22.1,Haemangioma of liver,3,15943098
0,22.0,Product use in unapproved indication,6,15943263
1,22.0,Malignant neoplasm progression,5,15943263
0,22.0,Product use in unapproved indication,6,15943265
1,22.0,Malignant neoplasm progression,5,15943265
0,22.0,Malignant neoplasm progression,5,15943392
1,22.0,Intentional product use issue,6,15943392
0,21.1,Hypothyroidism,2,15943402
1,21.1,Mucosal inflammation,2,15943402
2,21.1,Asthenia,3,15943402
3,21.1,Dyspnoea,3,15943402
0,22.0,Diabetic metabolic decompensation,1,15943403
0,22.1,Blood alkaline phosphatase increased,2,15943419
1,22.1,Protein deficiency,6,15943419
2,22.1,Blood urea increased,6,15943419
3,22.1,Eosinophil count increased,6,15943419
4,22.1,Starvation,1,15943419
5,22.1,Blood albumin decreased,1,15943419
6,22.1,Lymphocyte count decreased,6,15943419
7,22.1,Gamma-glutamyltransferase increased,2,15943419
8,22.1,C-reactive protein increased,6,15943419
0,21.1,Death,5,15943423
0,22.0,Death,5,15943425
1,22.0,Product use in unapproved indication,6,15943425
0,21.1,Lymphadenopathy,6,15943442
1,21.1,Performance status decreased,6,15943442
2,21.1,Hepatic neoplasm,6,15943442
3,21.1,PIK3CA-activated mutation,6,15943442
4,21.1,PTEN gene mutation,6,15943442
5,21.1,Abdominal neoplasm,6,15943442
0,22.0,Death,5,15943486
1,22.0,Product use in unapproved indication,6,15943486
0,21.1,Lung disorder,4,15943488
0,22.0,Dyspnoea,6,15943499
1,22.0,Chest pain,6,15943499
2,22.0,Fatigue,3,15943499
3,22.0,Asthenia,3,15943499
4,22.0,Dizziness,6,15943499
5,22.0,Head injury,6,15943499
6,22.0,Constipation,6,15943499
7,22.0,Breast pain,6,15943499
8,22.0,Cerebral haemorrhage,2,15943499
9,22.0,Back pain,6,15943499
10,22.0,Fall,1,15943499
11,22.0,Pain in extremity,6,15943499
12,22.0,Blood pressure increased,6,15943499
0,21.1,Glaucoma,3,15943507
1,21.1,Visual field defect,3,15943507
0,22.0,Metastases to peritoneum,5,15943534
1,22.0,Metastases to pleura,5,15943534
2,22.0,Renal cancer metastatic,5,15943534
3,22.0,Malignant neoplasm progression,5,15943534
0,21.1,Osteonecrosis of jaw,6,15943564
0,21.1,Osteonecrosis,1,15943587
0,21.1,Death,5,15943657
0,21.1,Renal failure,5,15943673
1,21.1,Diplopia,5,15943673
2,21.1,Dehydration,5,15943673
0,22.0,Liver function test increased,1,15943677
0,21.1,Drug ineffective,6,15943689
0,21.1,Hot flush,6,15943731
1,21.1,Alopecia,3,15943731
0,21.1,Sepsis,1,15943778
0,21.1,Pneumonitis,5,15943998
0,22.0,Decreased appetite,3,15944040
1,22.0,Diarrhoea,3,15944040
2,22.0,Gastric haemorrhage,3,15944040
3,22.0,Melaena,3,15944040
0,21.1,Prostate cancer,5,15944053
0,22.0,Pneumonia influenzal,5,15944054
0,22.0,Death,5,15944090
1,22.0,Product use in unapproved indication,6,15944090
0,22.1,Death,5,15944115
1,22.1,Intentional product use issue,6,15944115
0,21.1,Abdominal pain upper,1,15944155
1,21.1,Chills,1,15944155
2,21.1,Malaise,1,15944155
0,21.1,Product use in unapproved indication,6,15944217
1,21.1,Death,5,15944217
0,21.1,Anastomotic leak,6,15944229
0,21.1,Mucosal inflammation,6,15944327
1,21.1,Diarrhoea,6,15944327
2,21.1,Neutropenia,6,15944327
0,21.1,Haematochezia,6,15944342
0,21.1,Pneumonia,2,15944378
0,21.1,Death,5,15944408
0,21.1,Metastases to pelvis,1,15944442
1,21.1,Metastases to peritoneum,1,15944442
2,21.1,Neutropenia,6,15944442
3,21.1,Rash,6,15944442
4,21.1,Diarrhoea,6,15944442
0,21.1,Dyspnoea,1,15944601
1,21.1,Disease progression,3,15944601
2,21.1,Dermatitis allergic,1,15944601
0,21.1,Blood urine present,6,15944623
0,22.0,Renal impairment,1,15944651
0,21.1,Interstitial lung disease,3,15944702
1,21.1,Dyspnoea exertional,6,15944702
2,21.1,Cough,6,15944702
0,21.1,Hypokalaemia,5,15945150
1,21.1,Pyelonephritis,5,15945150
0,22.0,Alopecia,2,15945247
1,22.0,Psychological trauma,6,15945247
0,22.0,Alopecia,2,15945268
0,21.1,Malignant neoplasm progression,5,15945485
0,21.1,Death,5,15945506
1,21.1,Product use in unapproved indication,6,15945506
0,22.1,Prostate cancer metastatic,,15945513
0,21.1,Haemoglobin decreased,2,15945517
0,21.1,Oedema peripheral,3,15945533
1,21.1,Dyspnoea,3,15945533
2,21.1,Weight increased,3,15945533
3,21.1,Fluid retention,3,15945533
0,22.0,Psychological trauma,6,15945554
1,22.0,Alopecia,3,15945554
0,21.1,Neutropenic sepsis,5,15945561
0,22.1,Headache,3,15945584
1,22.1,Vomiting,1,15945584
2,22.1,Dizziness,3,15945584
3,22.1,Feeling of despair,6,15945584
4,22.1,Asthenia,6,15945584
5,22.1,Syncope,2,15945584
6,22.1,Inappropriate schedule of product administration,6,15945584
0,21.1,Proteinuria,3,15945599
1,21.1,Hypersensitivity,1,15945599
2,21.1,Diarrhoea,1,15945599
3,21.1,Vomiting,1,15945599
4,21.1,Fatigue,3,15945599
5,21.1,Dry skin,3,15945599
6,21.1,Anaemia,1,15945599
0,22.1,Hypocalcaemia,6,15945600
1,22.1,Infection,1,15945600
2,22.1,Lymphocyte count decreased,1,15945600
3,22.1,Constipation,3,15945600
4,22.1,Dry eye,6,15945600
5,22.1,Hypertension,1,15945600
6,22.1,Dermatitis acneiform,3,15945600
7,22.1,Epistaxis,3,15945600
8,22.1,Mucosal inflammation,3,15945600
9,22.1,Fatigue,3,15945600
0,21.1,General physical health deterioration,1,15945601
1,21.1,Vomiting,1,15945601
2,21.1,Nausea,1,15945601
3,21.1,Upper gastrointestinal haemorrhage,1,15945601
4,21.1,Spinal pain,6,15945601
5,21.1,Duodenal ulcer repair,6,15945601
6,21.1,Helicobacter gastritis,6,15945601
7,21.1,Malignant neoplasm progression,3,15945601
8,21.1,Decreased appetite,1,15945601
0,21.1,Dermatitis acneiform,6,15945604
0,21.1,Ileus,6,15945605
0,21.1,Stomatitis,1,15945607
1,21.1,Dysphagia,1,15945607
2,21.1,Hyperkalaemia,1,15945607
3,21.1,General physical health deterioration,1,15945607
4,21.1,Pancytopenia,1,15945607
5,21.1,Acute kidney injury,1,15945607
6,21.1,Diarrhoea,1,15945607
0,22.0,Leukopenia,1,15945608
1,22.0,Circulatory collapse,1,15945608
2,22.0,Pancytopenia,1,15945608
3,22.0,General physical health deterioration,1,15945608
4,22.0,Thrombocytopenia,1,15945608
5,22.0,Seizure,1,15945608
0,21.1,Anaphylactic reaction,2,15945613
0,21.1,Back pain,1,15945614
1,21.1,Muscle spasms,1,15945614
0,21.1,Hypokalaemia,4,15945622
1,21.1,Hypocalcaemia,4,15945622
2,21.1,Hypomagnesaemia,4,15945622
3,21.1,Vomiting,4,15945622
0,21.1,Aplasia,1,15945629
1,21.1,Lung disorder,1,15945629
0,21.1,Neutropenia,1,15945634
1,21.1,Hepatic function abnormal,1,15945634
2,21.1,Leukopenia,1,15945634
3,21.1,Thrombocytopenia,1,15945634
4,21.1,Palmar-plantar erythrodysaesthesia syndrome,1,15945634
5,21.1,Stomatitis,1,15945634
6,21.1,Alopecia,1,15945634
7,21.1,Phlebitis,1,15945634
8,21.1,Anaemia,1,15945634
9,21.1,Gastrointestinal disorder,1,15945634
10,21.1,Liver injury,1,15945634
0,21.1,Hypoxia,5,15945638
1,21.1,Decreased appetite,5,15945638
2,21.1,Asthenia,5,15945638
3,21.1,General physical health deterioration,5,15945638
0,22.0,Leukopenia,2,15945648
1,22.0,Sneezing,6,15945648
2,22.0,Rhinorrhoea,6,15945648
3,22.0,Sinus congestion,3,15945648
4,22.0,Intentional product misuse,6,15945648
5,22.0,Bone marrow failure,3,15945648
6,22.0,Sleep disorder,6,15945648
7,22.0,Nasopharyngitis,2,15945648
8,22.0,Headache,6,15945648
9,22.0,Arthralgia,6,15945648
10,22.0,Cough,6,15945648
11,22.0,Product dose omission,6,15945648
0,21.1,Osteonecrosis of jaw,3,15945690
1,21.1,Osteitis,3,15945690
0,21.1,Lung infiltration,1,15945695
1,21.1,Cardiac failure,1,15945695
2,21.1,Arrhythmia,1,15945695
3,21.1,Angina pectoris,1,15945695
4,21.1,Fatigue,3,15945695
5,21.1,Vascular graft,2,15945695
0,21.1,Acute myeloid leukaemia,5,15945712
0,21.1,Infusion related reaction,2,15945753
0,21.1,Hepatic function abnormal,6,15945792
1,21.1,Decreased appetite,6,15945792
2,21.1,Febrile neutropenia,6,15945792
3,21.1,Granulocytopenia,6,15945792
4,21.1,Bone marrow failure,6,15945792
5,21.1,Alopecia,6,15945792
6,21.1,Haematotoxicity,6,15945792
7,21.1,White blood cell count decreased,6,15945792
8,21.1,Nausea,6,15945792
9,21.1,Vomiting,6,15945792
0,21.1,Drug ineffective,3,15945804
0,22.0,Death,5,15945883
1,22.0,Off label use,6,15945883
0,22.0,Steroid diabetes,6,15945895
1,22.0,Coating in mouth,6,15945895
2,22.0,Malignant neoplasm progression,5,15945895
3,22.0,Red blood cell count decreased,1,15945895
4,22.0,Platelet count decreased,1,15945895
5,22.0,Immune thrombocytopenic purpura,6,15945895
6,22.0,Anaphylactic shock,1,15945895
0,22.0,Death,5,15945919
0,22.0,Death,5,15945967
0,21.1,Generalised erythema,1,15945983
1,21.1,Rash pruritic,1,15945983
0,21.1,Leukopenia,6,15945989
1,21.1,Aspartate aminotransferase increased,6,15945989
2,21.1,Neutropenia,6,15945989
3,21.1,Alanine aminotransferase increased,6,15945989
0,21.1,Injection site swelling,6,15946044
1,21.1,Injection site pruritus,6,15946044
2,21.1,Injection site erythema,6,15946044
0,21.1,Metastases to liver,6,15946049
1,21.1,Ejection fraction decreased,3,15946049
2,21.1,Metastases to lung,6,15946049
0,21.1,Electrocardiogram QT prolonged,6,15946060
0,22.0,Blood pressure fluctuation,6,15946061
1,22.0,Malignant neoplasm progression,6,15946061
2,22.0,Insomnia,6,15946061
3,22.0,Haemoglobin decreased,6,15946061
4,22.0,White blood cell count decreased,6,15946061
5,22.0,Heart rate increased,6,15946061
6,22.0,Full blood count decreased,6,15946061
7,22.0,Inappropriate schedule of product administration,6,15946061
8,22.0,Platelet count decreased,6,15946061
9,22.0,Fatigue,6,15946061
10,22.0,Abdominal pain upper,6,15946061
0,22.0,Interstitial lung disease,5,15946122
1,22.0,Multiple organ dysfunction syndrome,6,15946122
0,22.0,Cholangitis,3,15946149
1,22.0,Off label use,6,15946149
2,22.0,Malignant neoplasm progression,6,15946149
0,21.1,General physical health deterioration,1,15946174
0,21.1,Dyspepsia,6,15946188
1,21.1,Vomiting,6,15946188
2,21.1,Neutropenia,6,15946188
3,21.1,Abdominal pain,6,15946188
0,21.1,Bladder neck obstruction,3,15946202
0,21.1,Rash,6,15946216
1,21.1,Skin irritation,6,15946216
0,21.1,Blood pressure decreased,6,15946224
1,21.1,Fatigue,6,15946224
0,21.1,Neoplasm progression,6,15946248
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15946248
0,21.1,Decreased appetite,2,15946251
1,21.1,Lung disorder,1,15946251
2,21.1,Weight decreased,2,15946251
3,21.1,Gastrointestinal disorder,1,15946251
0,22.1,Pain,1,15946252
1,22.1,Hypophagia,6,15946252
2,22.1,Oesophagitis,1,15946252
3,22.1,Nausea,1,15946252
4,22.1,Hypocalcaemia,6,15946252
5,22.1,C-reactive protein increased,6,15946252
6,22.1,Leukopenia,6,15946252
0,21.1,Dysgeusia,3,15946286
0,21.1,Metastases to bone,3,15946362
1,21.1,Leukopenia,3,15946362
2,21.1,Neutropenia,1,15946362
3,21.1,Neutropenia,1,15946362
4,21.1,Leukopenia,1,15946362
5,21.1,Neutropenia,3,15946362
6,21.1,Cardiac failure,3,15946362
7,21.1,Neutropenia,1,15946362
8,21.1,Aortic valve incompetence,3,15946362
0,21.1,Influenza like illness,6,15946403
1,21.1,Asthenia,6,15946403
2,21.1,Nausea,6,15946403
0,21.1,Renal failure,6,15946418
1,21.1,Ejection fraction decreased,6,15946418
2,21.1,Deep vein thrombosis,1,15946418
3,21.1,Pulmonary embolism,1,15946418
0,22.0,Cholangitis,2,15946481
0,21.1,Prostate cancer,4,15946487
0,21.1,Chills,6,15946501
1,21.1,Hyperhidrosis,6,15946501
0,21.1,Toxicity to various agents,5,15946554
1,21.1,Ileus,6,15946554
2,21.1,Embolism,6,15946554
3,21.1,Myocardial infarction,6,15946554
0,22.0,Neutropenic sepsis,5,15946621
0,21.1,General physical health deterioration,5,15946623
1,21.1,Nausea,1,15946623
2,21.1,Asthenia,1,15946623
3,21.1,Asthenia,6,15946623
4,21.1,Gastritis,1,15946623
5,21.1,Palmar-plantar erythrodysaesthesia syndrome,1,15946623
6,21.1,Diarrhoea,1,15946623
7,21.1,Abdominal pain,1,15946623
8,21.1,Subileus,1,15946623
9,21.1,Nausea,1,15946623
10,21.1,Pain,1,15946623
11,21.1,Pulmonary embolism,3,15946623
12,21.1,Vertigo,1,15946623
0,21.1,Lipase increased,2,15946644
1,21.1,Amylase increased,2,15946644
0,22.0,Arteriovenous fistula occlusion,1,15946706
0,21.1,Red blood cell count decreased,6,15946725
1,21.1,Decreased appetite,6,15946725
2,21.1,Weight increased,6,15946725
0,22.0,Anal haemorrhage,1,15946887
0,22.0,Neutrophil count decreased,3,15946913
1,22.0,White blood cell count decreased,3,15946913
2,22.0,Fatigue,2,15946913
0,21.1,Neoplasm progression,6,15946938
1,21.1,Alopecia,6,15946938
0,21.1,Memory impairment,3,15946946
0,21.1,Neoplasm progression,6,15946954
0,22.1,Abdominal pain,6,15946963
1,22.1,Nasopharyngitis,3,15946963
2,22.1,Immune system disorder,6,15946963
3,22.1,Aphonia,6,15946963
4,22.1,Palmar-plantar erythrodysaesthesia syndrome,6,15946963
5,22.1,Dyspepsia,6,15946963
6,22.1,Headache,2,15946963
7,22.1,Cough,6,15946963
8,22.1,Sputum discoloured,6,15946963
9,22.1,Fatigue,6,15946963
10,22.1,Weight increased,6,15946963
11,22.1,Renal impairment,6,15946963
12,22.1,Flank pain,1,15946963
13,22.1,Nasal discharge discolouration,6,15946963
14,22.1,Productive cough,6,15946963
15,22.1,Malaise,6,15946963
16,22.1,Oropharyngeal pain,2,15946963
17,22.1,Stomatitis,2,15946963
18,22.1,Anaemia,6,15946963
19,22.1,Pharyngeal oedema,3,15946963
0,22.1,White blood cell count decreased,6,15946972
1,22.1,Sepsis,1,15946972
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15946975
0,21.1,Insomnia,6,15947006
1,21.1,Dyspepsia,6,15947006
2,21.1,Pain,6,15947006
3,21.1,Stomatitis,6,15947006
0,22.0,Mouth ulceration,1,15947024
1,22.0,Stomatitis,6,15947024
0,21.1,Electrocardiogram QT prolonged,2,15947038
0,22.0,White blood cell count decreased,3,15947087
1,22.0,Platelet count decreased,3,15947087
0,22.0,Weight increased,3,15947126
0,21.1,Pain,6,15947164
0,21.1,Metastases to adrenals,6,15947167
1,21.1,Ascites,6,15947167
2,21.1,Hiatus hernia,6,15947167
3,21.1,Subileus,6,15947167
4,21.1,Pain,6,15947167
5,21.1,Metastases to peritoneum,6,15947167
6,21.1,Bronchial carcinoma,6,15947167
7,21.1,Metastases to spleen,6,15947167
8,21.1,Vomiting,6,15947167
9,21.1,General physical health deterioration,6,15947167
10,21.1,Gastrooesophageal reflux disease,6,15947167
11,21.1,Acute kidney injury,6,15947167
12,21.1,Cachexia,6,15947167
0,22.0,Blood test abnormal,6,15947178
0,22.0,Neoplasm progression,6,15947261
0,21.1,General physical health deterioration,1,15947269
0,22.0,Neoplasm progression,6,15947272
0,21.1,Pulmonary embolism,3,15947327
0,22.1,Epistaxis,6,15947350
1,22.1,Alopecia,3,15947350
2,22.1,Nasal dryness,6,15947350
3,22.1,Lacrimation increased,3,15947350
4,22.1,Vulvovaginal dryness,3,15947350
5,22.1,Oral herpes,1,15947350
6,22.1,Headache,6,15947350
7,22.1,Myalgia,3,15947350
8,22.1,Rhinorrhoea,3,15947350
9,22.1,Stomatitis,1,15947350
10,22.1,Feeling cold,6,15947350
11,22.1,White blood cell count decreased,3,15947350
12,22.1,Dry eye,3,15947350
13,22.1,Pain,1,15947350
14,22.1,Diarrhoea,1,15947350
15,22.1,Asthenia,3,15947350
16,22.1,Fatigue,3,15947350
17,22.1,Feeling abnormal,3,15947350
18,22.1,Pyrexia,2,15947350
19,22.1,Chills,6,15947350
20,22.1,Blood count abnormal,3,15947350
21,22.1,Nausea,1,15947350
0,22.0,Nasopharyngitis,1,15947373
0,21.1,Lipase increased,2,15947381
1,21.1,Amylase increased,2,15947381
0,22.1,Sluggishness,6,15947382
1,22.1,White blood cell count decreased,6,15947382
2,22.1,Epistaxis,6,15947382
3,22.1,Nausea,6,15947382
0,22.0,Malaise,6,15947398
1,22.0,Cough,6,15947398
0,22.0,Blood pressure increased,3,15947411
1,22.0,Dizziness,3,15947411
2,22.0,Fatigue,6,15947411
3,22.0,Asthenia,6,15947411
4,22.0,Breast pain,3,15947411
5,22.0,Fall,3,15947411
6,22.0,Dyspnoea,3,15947411
7,22.0,Cerebral haemorrhage,3,15947411
8,22.0,Back pain,3,15947411
9,22.0,Pain in extremity,3,15947411
10,22.0,Chest pain,3,15947411
0,21.1,Cardiac disorder,6,15947458
1,21.1,Heart valve incompetence,6,15947458
2,21.1,Fatigue,6,15947458
0,22.0,Neoplasm progression,6,15947485
0,21.1,Drug-induced liver injury,1,15947540
1,21.1,Hepatic enzyme increased,1,15947540
0,22.0,Drug hypersensitivity,6,15947565
1,22.0,Neoplasm progression,6,15947565
0,21.1,Vision blurred,3,15947569
1,21.1,Eye haemorrhage,6,15947569
2,21.1,Eye oedema,6,15947569
0,22.0,Nausea,3,15947592
1,22.0,Diarrhoea,6,15947592
2,22.0,Bone lesion,6,15947592
3,22.0,Pancreatitis,2,15947592
4,22.0,Asthenia,3,15947592
5,22.0,Dry skin,2,15947592
6,22.0,Dehydration,2,15947592
7,22.0,Dizziness,1,15947592
8,22.0,Pruritus,3,15947592
9,22.0,Rash,3,15947592
0,22.1,Fungaemia,6,15947692
1,22.1,Infective spondylitis,6,15947692
2,22.1,Septic pulmonary embolism,6,15947692
3,22.1,Liver disorder,2,15947692
4,22.1,Bacteraemia,6,15947692
0,21.1,Febrile neutropenia,6,15947706
0,21.1,Confusional state,6,15947711
1,21.1,Delirium,6,15947711
2,21.1,Cognitive disorder,6,15947711
0,22.0,Rash,1,15947718
0,21.1,Malignant neoplasm progression,3,15947731
1,21.1,Metastases to bone,6,15947731
2,21.1,Metastases to liver,6,15947731
3,21.1,Tumour marker increased,6,15947731
0,21.1,Cranial nerve disorder,6,15947740
0,21.1,Gastrointestinal stromal tumour,6,15947817
1,21.1,Malignant neoplasm progression,6,15947817
0,21.1,Febrile neutropenia,1,15947822
0,21.1,Cardiac failure,6,15947844
0,21.1,Off label use,6,15947866
1,21.1,Fatigue,6,15947866
2,21.1,Myalgia,6,15947866
0,21.1,Inguinal hernia,6,15947883
0,21.1,Unevaluable event,6,15947884
1,21.1,Reflux gastritis,6,15947884
2,21.1,Oesophagitis,6,15947884
0,21.1,Anhidrosis,3,15947909
1,21.1,Malaise,3,15947909
2,21.1,Skin atrophy,3,15947909
3,21.1,Head discomfort,3,15947909
4,21.1,Dermatitis,3,15947909
5,21.1,Nail growth abnormal,3,15947909
6,21.1,Loss of personal independence in daily activities,3,15947909
7,21.1,Temperature intolerance,3,15947909
8,21.1,Aphthous ulcer,3,15947909
0,21.1,Cholecystitis,1,15947910
0,21.1,Diarrhoea,3,15947927
0,22.0,Dysstasia,6,15947949
1,22.0,Asthenia,6,15947949
2,22.0,Impaired self-care,6,15947949
0,21.1,Febrile neutropenia,1,15947986
1,21.1,Mouth ulceration,3,15947986
2,21.1,Rib fracture,1,15947986
3,21.1,Appendicitis,1,15947986
4,21.1,Mouth ulceration,1,15947986
5,21.1,Rash,1,15947986
6,21.1,Lower respiratory tract infection,1,15947986
7,21.1,Musculoskeletal chest pain,3,15947986
8,21.1,Urinary tract infection,1,15947986
9,21.1,Neuropathy peripheral,2,15947986
0,21.1,Constipation,1,15948051
1,21.1,General physical health deterioration,2,15948051
0,21.1,Drug resistance,6,15948114
0,21.1,Osteonecrosis,6,15948131
0,21.1,Joint stiffness,6,15948160
1,21.1,Arthralgia,6,15948160
0,22.1,Orthostatic hypotension,3,15948218
1,22.1,Intestinal obstruction,1,15948218
2,22.1,Dermatitis allergic,1,15948218
3,22.1,Neutropenia,1,15948218
4,22.1,Small intestinal obstruction,1,15948218
5,22.1,Pyrexia,1,15948218
6,22.1,Cholangitis acute,1,15948218
7,22.1,Benign prostatic hyperplasia,3,15948218
8,22.1,Platelet count decreased,3,15948218
9,22.1,Obstruction gastric,1,15948218
10,22.1,Diarrhoea,3,15948218
11,22.1,Stomatitis,1,15948218
12,22.1,Anaemia,3,15948218
0,22.0,Bicytopenia,3,15948241
1,22.0,Orbital myositis,3,15948241
2,22.0,Polymyositis,5,15948241
0,22.1,Alopecia,2,15948274
0,21.1,Blood pressure decreased,2,15948283
1,21.1,Erythema,2,15948283
2,21.1,Oral pruritus,2,15948283
3,21.1,Bronchospasm,2,15948283
4,21.1,Tachycardia,2,15948283
5,21.1,Pruritus,2,15948283
6,21.1,Hypersensitivity,2,15948283
7,21.1,Dyspnoea,2,15948283
0,22.0,Psychological trauma,6,15948388
1,22.0,Alopecia,3,15948388
0,22.0,Skin disorder,6,15948440
1,22.0,Injection site pruritus,6,15948440
2,22.0,Conjunctivitis,6,15948440
3,22.0,Product use in unapproved indication,6,15948440
4,22.0,Product dose omission,3,15948440
5,22.0,Erythema,6,15948440
0,21.1,Acne,3,15948493
1,21.1,Vomiting,1,15948493
0,21.1,Alopecia,3,15948495
0,21.1,Synovial cyst,3,15948500
1,21.1,Aortic aneurysm,3,15948500
2,21.1,Infection,1,15948500
3,21.1,Paraesthesia,3,15948500
4,21.1,Fall,6,15948500
5,21.1,Abdominal pain,1,15948500
6,21.1,Depression,3,15948500
7,21.1,Constipation,3,15948500
8,21.1,Nausea,1,15948500
9,21.1,Vomiting,1,15948500
10,21.1,Sleep disorder,3,15948500
11,21.1,Gastroenteritis,1,15948500
12,21.1,Microangiopathy,3,15948500
13,21.1,Upper respiratory tract infection,1,15948500
14,21.1,Dyspnoea exertional,3,15948500
15,21.1,Diarrhoea,1,15948500
16,21.1,Asthenia,3,15948500
17,21.1,Peripheral sensorimotor neuropathy,3,15948500
18,21.1,Nocturia,3,15948500
19,21.1,Dyspnoea,3,15948500
20,21.1,Osteoarthritis,3,15948500
21,21.1,Dizziness,3,15948500
22,21.1,Pulmonary hypertension,3,15948500
23,21.1,Cholecystitis acute,1,15948500
24,21.1,Osteochondrosis,3,15948500
25,21.1,Weight decreased,3,15948500
26,21.1,Left ventricular hypertrophy,1,15948500
27,21.1,Left atrial dilatation,3,15948500
0,22.1,Alopecia,2,15948501
0,22.1,Mucosal inflammation,1,15948505
1,22.1,Cough,3,15948505
2,22.1,Dysgeusia,1,15948505
3,22.1,Diarrhoea,3,15948505
4,22.1,Vertigo,1,15948505
5,22.1,Dysuria,3,15948505
6,22.1,Neutropenia,1,15948505
7,22.1,Epistaxis,1,15948505
8,22.1,Febrile neutropenia,3,15948505
0,22.0,Pruritus,1,15948513
1,22.0,Anaemia,1,15948513
2,22.0,Polyneuropathy,1,15948513
3,22.0,Nail toxicity,1,15948513
4,22.0,Diarrhoea,1,15948513
5,22.0,Back pain,1,15948513
6,22.0,Epistaxis,1,15948513
7,22.0,Febrile neutropenia,3,15948513
8,22.0,Alopecia,1,15948513
9,22.0,Neutropenia,1,15948513
10,22.0,Nasopharyngitis,1,15948513
11,22.0,Skin toxicity,1,15948513
0,21.1,Cardiac failure,6,15948518
1,21.1,Pallor,6,15948518
2,21.1,Ascites,6,15948518
3,21.1,Nitrituria,6,15948518
4,21.1,Blood pressure decreased,6,15948518
5,21.1,Anaemia,2,15948518
6,21.1,General physical health deterioration,6,15948518
7,21.1,Venous occlusion,5,15948518
8,21.1,Fall,6,15948518
9,21.1,Back pain,6,15948518
10,21.1,Hepatic enzyme increased,5,15948518
11,21.1,Multiple organ dysfunction syndrome,5,15948518
12,21.1,Dyspnoea exertional,6,15948518
13,21.1,Urinary tract infection bacterial,6,15948518
14,21.1,Circulatory collapse,6,15948518
15,21.1,Abdominal distension,6,15948518
16,21.1,Rales,6,15948518
17,21.1,Pleural effusion,6,15948518
18,21.1,Haemoglobin decreased,5,15948518
0,21.1,Acute kidney injury,2,15948536
0,22.1,Alopecia,2,15948564
1,22.1,Psychological trauma,6,15948564
0,21.1,Weight decreased,2,15948577
1,21.1,Campylobacter gastroenteritis,2,15948577
2,21.1,Paraesthesia oral,3,15948577
0,22.0,Atrioventricular block complete,6,15948586
1,22.0,Electrocardiogram QT prolonged,3,15948586
0,21.1,Rash pruritic,1,15948589
1,21.1,Malaise,1,15948589
2,21.1,Electrocardiogram ST-T change,1,15948589
3,21.1,Brain natriuretic peptide increased,3,15948589
4,21.1,Troponin increased,3,15948589
0,21.1,Hot flush,,15948668
1,21.1,Nausea,,15948668
2,21.1,Decreased appetite,,15948668
0,21.1,Acute kidney injury,1,15948703
1,21.1,Hormone-refractory prostate cancer,2,15948703
2,21.1,Prostate cancer metastatic,3,15948703
3,21.1,Hydronephrosis,2,15948703
0,22.1,Fatigue,6,15948730
1,22.1,Thrombocytopenia,2,15948730
2,22.1,Hot flush,3,15948730
3,22.1,Pain,2,15948730
4,22.1,Neutropenia,2,15948730
0,21.1,Hepatic necrosis,3,15948740
0,21.1,Intestinal obstruction,5,15948747
0,21.1,Pancytopenia,6,15948762
1,21.1,Platelet count decreased,6,15948762
0,21.1,Off label use,6,15948770
1,21.1,Inappropriate schedule of product administration,6,15948770
0,21.1,Swelling,2,15948877
1,21.1,Extravasation,2,15948877
0,21.1,Nephrotic syndrome,2,15948879
1,21.1,Thrombotic microangiopathy,2,15948879
2,21.1,Generalised oedema,2,15948879
0,21.1,Laryngeal oedema,3,15948884
1,21.1,Stridor,3,15948884
2,21.1,Anaphylactic shock,3,15948884
3,21.1,Dyspnoea,3,15948884
4,21.1,Tachycardia,3,15948884
5,21.1,Hypotension,3,15948884
6,21.1,Loss of consciousness,3,15948884
0,21.1,Alanine aminotransferase increased,2,15948893
1,21.1,Liver injury,2,15948893
2,21.1,Aspartate aminotransferase increased,2,15948893
0,21.1,Visual field defect,1,15948904
0,21.1,Oligohydramnios,3,15948950
0,21.1,Cerebral infarction,3,15948968
1,21.1,Trousseau^s syndrome,2,15948968
2,21.1,Off label use,6,15948968
3,21.1,Malignant neoplasm progression,5,15948968
0,21.1,Adverse event,6,15949052
1,21.1,Adverse event,6,15949052
0,22.0,Liver disorder,2,15949118
1,22.0,Haemophagocytic lymphohistiocytosis,2,15949118
2,22.0,Rash,2,15949118
3,22.0,Pyrexia,1,15949118
0,22.0,Death,5,15949125
1,22.0,Product use in unapproved indication,6,15949125
0,22.0,Death,5,15949129
0,21.1,Nausea,6,15949135
1,21.1,Bone lesion,6,15949135
2,21.1,Asthenia,6,15949135
3,21.1,Fatigue,6,15949135
4,21.1,Back pain,6,15949135
5,21.1,Blood pressure increased,6,15949135
6,21.1,Oral pain,6,15949135
0,21.1,Dry mouth,,15949148
1,21.1,Dysgeusia,,15949148
0,21.1,Death,5,15949170
0,21.1,Death,5,15949180
0,22.0,Interstitial lung disease,6,15949184
1,22.0,Malignant neoplasm progression,6,15949184
2,22.0,Adrenal insufficiency,6,15949184
3,22.0,Hypoglycaemia,6,15949184
0,21.1,Pneumonia,2,15949199
1,21.1,Therapy cessation,1,15949199
0,22.0,Hypotension,1,15949255
1,22.0,Adrenal insufficiency,4,15949255
2,22.0,Addison^s disease,6,15949255
3,22.0,Lower respiratory tract infection,1,15949255
4,22.0,Body temperature,1,15949255
5,22.0,Endocrine toxicity,6,15949255
6,22.0,Malignant neoplasm progression,6,15949255
7,22.0,Rash,1,15949255
8,22.0,Rash,1,15949255
9,22.0,Oxygen saturation abnormal,1,15949255
10,22.0,Blood pressure decreased,1,15949255
0,21.1,Gait disturbance,,15949265
1,21.1,Peripheral swelling,,15949265
2,21.1,Pain in extremity,,15949265
0,22.0,Renal failure,6,15949293
0,22.0,Malignant neoplasm progression,6,15949308
1,22.0,Cerebral infarction,2,15949308
0,21.1,Urticaria,6,15949347
1,21.1,Asthenia,6,15949347
2,21.1,Product dose omission,6,15949347
3,21.1,Fatigue,6,15949347
4,21.1,Memory impairment,6,15949347
0,21.1,Cerebrovascular accident,5,15949484
1,21.1,Platelet count decreased,3,15949484
2,21.1,Troponin I increased,3,15949484
0,21.1,Eye disorder,3,15949581
1,21.1,Feeling abnormal,6,15949581
2,21.1,Positron emission tomogram abnormal,6,15949581
3,21.1,Drug ineffective,6,15949581
4,21.1,Condition aggravated,6,15949581
5,21.1,Pain,2,15949581
6,21.1,Deep vein thrombosis,1,15949581
7,21.1,Swelling,2,15949581
8,21.1,Metabolic function test abnormal,6,15949581
0,22.0,Intestinal obstruction,1,15949663
0,22.1,Mental disorder,6,15949666
0,21.1,Fatigue,,15949690
0,21.1,Sensitivity of teeth,2,15949700
1,21.1,Gingival recession,3,15949700
0,21.1,Hernia,3,15949711
1,21.1,Cerebrovascular accident,6,15949711
0,21.1,Withdrawal syndrome,3,15949719
1,21.1,Muscle atrophy,3,15949719
2,21.1,Weight decreased,3,15949719
0,22.0,Product use in unapproved indication,6,15949741
1,22.0,Neutropenia,1,15949741
0,21.1,Hepatic enzyme increased,6,15949770
0,21.1,Pneumonitis,1,15949778
0,22.0,Fatigue,6,15949856
1,22.0,Hypoaesthesia,6,15949856
2,22.0,Bone marrow failure,6,15949856
3,22.0,Somnolence,6,15949856
4,22.0,Leukopenia,3,15949856
0,22.0,Sarcoidosis,3,15949873
0,22.0,Chronic kidney disease,6,15949907
1,22.0,Peripheral swelling,6,15949907
2,22.0,Confusional state,3,15949907
3,22.0,Anaemia of malignant disease,6,15949907
4,22.0,Product dose omission,6,15949907
5,22.0,Pyelonephritis acute,6,15949907
6,22.0,Skin disorder,6,15949907
0,21.1,Death,5,15949919
1,21.1,Confusional state,3,15949919
0,22.0,Mental impairment,3,15949964
0,21.1,Death,5,15949971
1,21.1,Colon cancer metastatic,6,15949971
0,21.1,Diarrhoea,6,15949982
0,21.1,Typhoid fever,6,15949988
0,21.1,Myeloid leukaemia,5,15950031
0,21.1,Off label use,6,15950043
1,21.1,Exposed bone in jaw,2,15950043
0,21.1,Agranulocytosis,2,15950049
1,21.1,Alopecia,3,15950049
0,22.0,Coronary artery stenosis,2,15950056
1,22.0,Drug ineffective,6,15950056
2,22.0,Haemorrhage urinary tract,6,15950056
3,22.0,Acute myocardial infarction,2,15950056
0,21.1,Dyspnoea,1,15950071
1,21.1,Back pain,1,15950071
2,21.1,Hot flush,1,15950071
0,21.1,Glucose tolerance impaired,3,15950082
1,21.1,Oesophagitis,1,15950082
2,21.1,Atrial fibrillation,1,15950082
3,21.1,Duodenal ulcer,1,15950082
4,21.1,Nausea,1,15950082
5,21.1,Leukocytosis,1,15950082
6,21.1,Vomiting,1,15950082
7,21.1,Acidosis,1,15950082
8,21.1,Abdominal pain,1,15950082
9,21.1,Hyperglycaemia,3,15950082
0,21.1,Lung operation,,15950097
0,22.0,Vulvovaginal burning sensation,2,15950118
1,22.0,Product use in unapproved indication,6,15950118
2,22.0,Vulvovaginal pruritus,2,15950118
3,22.0,Rash erythematous,2,15950118
4,22.0,Nasopharyngitis,3,15950118
0,21.1,Chromaturia,3,15950127
1,21.1,Alanine aminotransferase increased,6,15950127
2,21.1,Constipation,3,15950127
3,21.1,Blood alkaline phosphatase increased,6,15950127
4,21.1,Faeces pale,1,15950127
0,21.1,Animal bite,6,15950128
0,21.1,Feeling abnormal,6,15950153
1,21.1,Drug ineffective,6,15950153
0,21.1,Cholecystitis acute,1,15950168
0,22.0,Hepatic haemorrhage,1,15950184
0,21.1,General physical health deterioration,3,15950192
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,1,15950192
2,21.1,Hepatic function abnormal,2,15950192
3,21.1,Colon cancer,5,15950192
4,21.1,Loss of personal independence in daily activities,3,15950192
0,22.0,Memory impairment,3,15950199
1,22.0,Death,5,15950199
2,22.0,Malignant neoplasm progression,6,15950199
3,22.0,Confusional state,3,15950199
0,21.1,Thrombotic microangiopathy,2,15950213
0,21.1,Myalgia,6,15950390
1,21.1,Rash,6,15950390
2,21.1,Neoplasm progression,6,15950390
3,21.1,Constipation,6,15950390
4,21.1,Skin hypertrophy,6,15950390
5,21.1,Arthralgia,6,15950390
6,21.1,Musculoskeletal stiffness,6,15950390
0,21.1,Neoplasm progression,5,15950411
0,21.1,Pain,2,15950445
1,21.1,Therapeutic response decreased,6,15950445
2,21.1,Drug interaction,6,15950445
0,22.1,Cerebrovascular accident,6,15950559
1,22.1,Hypoacusis,6,15950559
0,22.0,Neutropenia,1,15950580
1,22.0,Neoplasm progression,1,15950580
0,21.1,Malignant neoplasm progression,6,15950584
0,21.1,Product availability issue,6,15950591
1,21.1,No adverse event,6,15950591
2,21.1,Product dose omission,6,15950591
0,22.1,Sepsis,5,15950602
1,22.1,Pyrexia,3,15950602
2,22.1,White blood cell count decreased,3,15950602
3,22.1,Nausea,3,15950602
4,22.1,Multiple organ dysfunction syndrome,5,15950602
5,22.1,Platelet count decreased,3,15950602
0,21.1,Herpes zoster,2,15950610
0,21.1,Erysipelas,2,15950620
0,22.0,Interstitial lung disease,5,15950632
0,21.1,Lung disorder,2,15950638
0,21.1,Malignant neoplasm progression,6,15950658
1,21.1,Lung disorder,2,15950658
0,21.1,Lung disorder,2,15950661
0,22.1,Hepatic failure,1,15950695
1,22.1,Anaemia,1,15950695
0,21.1,Haematemesis,1,15950696
1,21.1,Varices oesophageal,1,15950696
2,21.1,Venoocclusive liver disease,1,15950696
3,21.1,Portal hypertension,1,15950696
4,21.1,Rectal haemorrhage,1,15950696
0,21.1,Mass,3,15950721
0,21.1,Cerebrovascular accident,6,15950748
1,21.1,Neoplasm progression,6,15950748
0,21.1,Pollakiuria,6,15950775
1,21.1,Malaise,6,15950775
2,21.1,Gait disturbance,6,15950775
3,21.1,Blood electrolytes decreased,6,15950775
4,21.1,Neoplasm progression,6,15950775
5,21.1,Seizure,6,15950775
6,21.1,Blood sodium decreased,6,15950775
0,21.1,Pain in extremity,3,15950827
1,21.1,Hypoaesthesia,3,15950827
2,21.1,Peripheral swelling,3,15950827
3,21.1,Paraesthesia,3,15950827
0,22.0,Pruritus,6,15950883
0,22.0,Alopecia,6,15950892
1,22.0,Pruritus,6,15950892
2,22.0,Squamous cell carcinoma of skin,2,15950892
3,22.0,Dizziness,6,15950892
4,22.0,Fall,6,15950892
5,22.0,Off label use,3,15950892
6,22.0,Blood cholesterol increased,6,15950892
7,22.0,Dry skin,6,15950892
0,21.1,Cerebral haemorrhage,5,15950915
0,22.0,White blood cell count decreased,1,15950945
1,22.0,Diarrhoea,3,15950945
2,22.0,Dehydration,6,15950945
3,22.0,Sepsis,5,15950945
4,22.0,Cardiac arrest,5,15950945
5,22.0,Bone marrow disorder,6,15950945
6,22.0,Platelet count decreased,3,15950945
0,21.1,Cardiogenic shock,5,15951002
0,21.1,Dizziness,6,15951028
1,21.1,Fall,1,15951028
2,21.1,Fall,6,15951028
3,21.1,Radiotherapy,6,15951028
4,21.1,Contusion,6,15951028
5,21.1,Fall,1,15951028
0,22.1,Retinopathy,6,15951084
0,21.1,Arthralgia,2,15951115
1,21.1,Decreased appetite,2,15951115
2,21.1,Insomnia,2,15951115
3,21.1,Nausea,2,15951115
4,21.1,Neuropathy peripheral,2,15951115
5,21.1,Fatigue,2,15951115
0,21.1,Diarrhoea,3,15951128
1,21.1,Malignant neoplasm progression,6,15951128
0,22.1,Dyspnoea,2,15951238
1,22.1,Haemorrhoids,6,15951238
2,22.1,Intentional product misuse,6,15951238
3,22.1,Diverticulitis,6,15951238
4,22.1,Headache,2,15951238
5,22.1,Lacrimation increased,6,15951238
6,22.1,Eye pruritus,6,15951238
7,22.1,Large intestine polyp,6,15951238
8,22.1,Peripheral swelling,6,15951238
9,22.1,Vitamin D decreased,2,15951238
10,22.1,Blood phosphorus decreased,6,15951238
11,22.1,Facial pain,6,15951238
12,22.1,Arthralgia,2,15951238
13,22.1,Stomatitis,2,15951238
14,22.1,Pain in extremity,6,15951238
15,22.1,Diarrhoea,6,15951238
16,22.1,Pain,2,15951238
17,22.1,Pain in jaw,6,15951238
18,22.1,Fatigue,3,15951238
19,22.1,Back pain,2,15951238
20,22.1,Visual impairment,6,15951238
21,22.1,Blood magnesium decreased,2,15951238
22,22.1,Blood potassium decreased,2,15951238
23,22.1,Joint swelling,2,15951238
24,22.1,Optic nerve disorder,6,15951238
25,22.1,Decreased appetite,2,15951238
0,21.1,Neoplasm progression,6,15951259
1,21.1,White blood cell count increased,6,15951259
2,21.1,Renal function test abnormal,3,15951259
3,21.1,Gallbladder disorder,6,15951259
4,21.1,Dehydration,6,15951259
5,21.1,Nausea,3,15951259
6,21.1,Fatigue,3,15951259
7,21.1,Abdominal pain,3,15951259
8,21.1,Renal disorder,6,15951259
9,21.1,Anaemia,3,15951259
10,21.1,Bronchitis,6,15951259
11,21.1,Asthenia,3,15951259
12,21.1,Dyspepsia,2,15951259
13,21.1,Back pain,3,15951259
14,21.1,Liver disorder,6,15951259
15,21.1,Chills,6,15951259
0,21.1,Second primary malignancy,5,15951273
1,21.1,Acute myeloid leukaemia,5,15951273
0,21.1,Second primary malignancy,5,15951275
1,21.1,Acute myeloid leukaemia,5,15951275
0,21.1,Second primary malignancy,6,15951280
1,21.1,Acute leukaemia,6,15951280
0,21.1,Headache,1,15951296
1,21.1,Chills,1,15951296
0,21.1,Malignant neoplasm progression,6,15951320
1,21.1,Non-small cell lung cancer,6,15951320
2,21.1,Anaplastic lymphoma kinase gene mutation,6,15951320
0,21.1,Diarrhoea,3,15951426
0,22.0,Palpitations,6,15951428
1,22.0,Diarrhoea,1,15951428
0,21.1,Underdose,6,15951442
1,21.1,Alopecia,3,15951442
0,22.0,Malaise,1,15951444
1,22.0,Vomiting,1,15951444
2,22.0,Therapy cessation,6,15951444
3,22.0,Diarrhoea,1,15951444
0,21.1,Ascites,5,15951495
0,22.0,Tinnitus,3,15951504
1,22.0,Deafness,3,15951504
2,22.0,Rash,1,15951504
0,21.1,Small intestinal perforation,3,15951517
0,21.1,Neutrophil count decreased,1,15951531
1,21.1,Hyperthyroidism,6,15951531
2,21.1,Onycholysis,4,15951531
3,21.1,Adrenocorticotropic hormone deficiency,6,15951531
0,21.1,Abdominal pain upper,1,15951547
1,21.1,Malaise,1,15951547
2,21.1,Chills,1,15951547
0,21.1,Faeces discoloured,3,15951552
1,21.1,Fatigue,1,15951552
2,21.1,Abdominal pain upper,1,15951552
3,21.1,Fatigue,3,15951552
0,21.1,Seizure,1,15951574
1,21.1,Constipation,3,15951574
2,21.1,Decreased appetite,3,15951574
3,21.1,Blood phosphorus decreased,3,15951574
4,21.1,Malignant neoplasm progression,2,15951574
5,21.1,Diarrhoea,1,15951574
6,21.1,Weight decreased,3,15951574
7,21.1,Eye pain,3,15951574
8,21.1,Vomiting,1,15951574
9,21.1,Blood pressure increased,3,15951574
10,21.1,Pneumothorax,2,15951574
11,21.1,Blood magnesium abnormal,3,15951574
12,21.1,Fatigue,3,15951574
13,21.1,Fall,3,15951574
14,21.1,Asthenia,3,15951574
15,21.1,Dizziness postural,2,15951574
16,21.1,Blood calcium abnormal,3,15951574
17,21.1,Pleurisy,3,15951574
18,21.1,Dyspnoea,3,15951574
19,21.1,Orthostatic hypotension,2,15951574
20,21.1,Pleural effusion,2,15951574
21,21.1,Cough,3,15951574
0,21.1,Malignant neoplasm progression,5,15951650
0,22.0,Fatigue,6,15951654
1,22.0,Liver function test increased,6,15951654
2,22.0,Nausea,6,15951654
3,22.0,Headache,6,15951654
0,21.1,Hair texture abnormal,3,15951656
1,21.1,Hair colour changes,3,15951656
2,21.1,Hair disorder,3,15951656
3,21.1,Alopecia,3,15951656
0,22.0,Madarosis,3,15951669
1,22.0,Alopecia,3,15951669
2,22.0,Hair texture abnormal,3,15951669
3,22.0,Hair disorder,3,15951669
4,22.0,Hair colour changes,3,15951669
0,22.1,White blood cell count decreased,6,15951673
1,22.1,Stomatitis,6,15951673
2,22.1,Blood count abnormal,6,15951673
0,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15951675
0,22.1,Fatigue,3,15951677
1,22.1,Oedema,6,15951677
2,22.1,Nasopharyngitis,1,15951677
3,22.1,Pain in extremity,6,15951677
4,22.1,Somnolence,1,15951677
5,22.1,Feeling abnormal,6,15951677
6,22.1,Dysarthria,6,15951677
7,22.1,Ear infection,6,15951677
0,21.1,Peripheral swelling,3,15951791
1,21.1,Diarrhoea,3,15951791
2,21.1,Fatigue,3,15951791
3,21.1,Rhinorrhoea,3,15951791
4,21.1,Hypoaesthesia,3,15951791
5,21.1,Back pain,3,15951791
0,21.1,Breast cancer,5,15951816
0,21.1,Headache,2,15951858
1,21.1,Neoplasm progression,2,15951858
2,21.1,Protein total increased,2,15951858
3,21.1,Platelet count decreased,2,15951858
4,21.1,Immunosuppression,2,15951858
5,21.1,Meningoencephalitis herpetic,2,15951858
6,21.1,Asthenia,2,15951858
0,22.0,Pulmonary embolism,6,15951860
1,22.0,Thrombophlebitis,6,15951860
0,21.1,Drug ineffective,,15951863
1,21.1,Oestradiol increased,6,15951863
2,21.1,Neoplasm progression,6,15951863
3,21.1,Tumour marker increased,6,15951863
0,21.1,Neoplasm progression,2,15951864
1,21.1,Fatigue,2,15951864
2,21.1,Colitis ulcerative,2,15951864
0,21.1,Gastrointestinal haemorrhage,6,15951868
0,21.1,Malignant neoplasm progression,6,15951873
1,21.1,Neutropenia,6,15951873
2,21.1,Asthenia,6,15951873
3,21.1,Fatigue,6,15951873
4,21.1,Pain,6,15951873
5,21.1,Tumour marker increased,6,15951873
0,21.1,Lacrimation increased,3,15951891
1,21.1,Nausea,3,15951891
2,21.1,Arthralgia,3,15951891
3,21.1,Lymphoedema,3,15951891
4,21.1,Muscle spasms,3,15951891
5,21.1,Myalgia,3,15951891
6,21.1,Epistaxis,3,15951891
7,21.1,Cellulitis,3,15951891
8,21.1,Diarrhoea,3,15951891
0,22.0,Escherichia sepsis,1,15951906
1,22.0,White blood cell count decreased,1,15951906
2,22.0,Neoplasm progression,6,15951906
3,22.0,Influenza,6,15951906
4,22.0,Nasopharyngitis,6,15951906
5,22.0,Neutropenia,6,15951906
6,22.0,Malaise,6,15951906
7,22.0,Vitamin B12 decreased,6,15951906
0,21.1,Hyperhidrosis,1,15952018
1,21.1,Oxygen saturation decreased,1,15952018
2,21.1,Vertigo,1,15952018
3,21.1,Hypotension,1,15952018
0,22.0,Malignant neoplasm progression,2,15952019
1,22.0,Bronchopulmonary aspergillosis allergic,2,15952019
0,21.1,Death,5,15952047
0,21.1,Febrile neutropenia,6,15952086
1,21.1,Pleural effusion,6,15952086
0,21.1,Drug intolerance,6,15952093
0,21.1,Second primary malignancy,6,15952098
1,21.1,Acute myeloid leukaemia,6,15952098
0,22.0,Cerebrovascular accident,5,15952102
0,21.1,Pain,6,15952118
1,21.1,Anxiety,6,15952118
2,21.1,Emotional distress,6,15952118
3,21.1,Impaired quality of life,6,15952118
4,21.1,Alopecia,2,15952118
0,21.1,Acute myeloid leukaemia,6,15952119
1,21.1,Second primary malignancy,6,15952119
0,21.1,Lung disorder,2,15952132
0,21.1,Emotional distress,6,15952141
1,21.1,Impaired quality of life,6,15952141
2,21.1,Anxiety,6,15952141
3,21.1,Pain,6,15952141
4,21.1,Alopecia,2,15952141
5,21.1,Psychological trauma,6,15952141
0,21.1,Hormone-refractory prostate cancer,,15952155
1,21.1,Blood pressure abnormal,3,15952155
2,21.1,Decreased appetite,3,15952155
3,21.1,Fall,3,15952155
4,21.1,Fatigue,3,15952155
0,22.0,Alopecia,3,15952169
1,22.0,Psychological trauma,6,15952169
0,21.1,Pancytopenia,3,15952193
1,21.1,Thrombocytopenia,3,15952193
2,21.1,Myelodysplastic syndrome,6,15952193
0,21.1,Neoplasm progression,6,15952235
1,21.1,General physical health deterioration,6,15952235
2,21.1,Product use in unapproved indication,6,15952235
0,21.1,Infection,6,15952279
1,21.1,Inflammation,6,15952279
2,21.1,Rash,6,15952279
3,21.1,Transaminases increased,6,15952279
4,21.1,Diarrhoea,6,15952279
5,21.1,Pneumonitis,6,15952279
0,21.1,Alopecia,3,15952307
1,21.1,Psychological trauma,6,15952307
0,22.0,Psychological trauma,6,15952326
1,22.0,Emotional distress,6,15952326
2,22.0,Alopecia,2,15952326
0,22.1,Pain,6,15952371
1,22.1,Impaired quality of life,6,15952371
2,22.1,Alopecia,3,15952371
3,22.1,Emotional distress,6,15952371
4,22.1,Anxiety,6,15952371
5,22.1,Psychological trauma,6,15952371
0,21.1,Visual impairment,1,15952399
1,21.1,Vision blurred,6,15952399
0,21.1,Death,5,15952400
0,22.0,White blood cell count decreased,2,15952481
1,22.0,Malaise,6,15952481
2,22.0,Platelet count decreased,2,15952481
3,22.0,Laboratory test abnormal,6,15952481
4,22.0,Full blood count decreased,2,15952481
0,22.1,Breast cancer metastatic,5,15952495
1,22.1,Type 2 diabetes mellitus,1,15952495
2,22.1,Myopathy,1,15952495
3,22.1,Syncope,1,15952495
4,22.1,Ascites,5,15952495
5,22.1,Malignant neoplasm progression,5,15952495
6,22.1,Hyperglycaemia,1,15952495
7,22.1,Abdominal distension,5,15952495
8,22.1,Renal pain,5,15952495
9,22.1,Pneumonia influenzal,1,15952495
0,22.0,Fatigue,6,15952502
1,22.0,Decreased appetite,6,15952502
2,22.0,Swelling face,6,15952502
3,22.0,Vomiting,6,15952502
4,22.0,Pain,6,15952502
5,22.0,Bone pain,6,15952502
6,22.0,Somnolence,6,15952502
7,22.0,Peripheral swelling,6,15952502
8,22.0,Constipation,6,15952502
0,21.1,Fatigue,6,15952505
0,21.1,Pneumonitis,6,15952506
0,21.1,Pleuritic pain,1,15952519
0,22.1,White blood cell count decreased,6,15952575
0,21.1,Bone marrow failure,1,15952594
0,21.1,Bone marrow failure,6,15952597
0,22.0,Madarosis,3,15952605
1,22.0,Alopecia,3,15952605
2,22.0,Hair texture abnormal,3,15952605
3,22.0,Hair disorder,3,15952605
4,22.0,Hair colour changes,3,15952605
0,22.0,Hair disorder,3,15952657
1,22.0,Alopecia,3,15952657
2,22.0,Madarosis,3,15952657
3,22.0,Hair texture abnormal,3,15952657
4,22.0,Hair colour changes,3,15952657
0,21.1,Madarosis,3,15952675
1,21.1,Hair texture abnormal,3,15952675
2,21.1,Hair colour changes,3,15952675
3,21.1,Alopecia,3,15952675
4,21.1,Hair disorder,3,15952675
5,21.1,Anxiety,3,15952675
0,21.1,Confusional state,6,15952693
1,21.1,Stress,6,15952693
0,21.1,Hair colour changes,3,15952694
1,21.1,Hair texture abnormal,3,15952694
2,21.1,Hair disorder,3,15952694
3,21.1,Madarosis,3,15952694
4,21.1,Alopecia,3,15952694
0,22.0,Death,5,15952697
0,22.1,Madarosis,3,15952698
1,22.1,Hair texture abnormal,3,15952698
2,22.1,Hair colour changes,3,15952698
3,22.1,Alopecia,3,15952698
4,22.1,Hair disorder,3,15952698
0,21.1,Febrile neutropenia,1,15952733
0,22.0,Hair colour changes,3,15952753
1,22.0,Hair texture abnormal,3,15952753
2,22.0,Alopecia,3,15952753
3,22.0,Hair disorder,3,15952753
0,22.0,Malignant neoplasm progression,5,15952758
0,22.1,Alopecia,3,15952759
1,22.1,Hair colour changes,3,15952759
2,22.1,Madarosis,3,15952759
3,22.1,Hair disorder,3,15952759
4,22.1,Hair texture abnormal,3,15952759
0,21.1,Alopecia,3,15952762
1,21.1,Hair texture abnormal,3,15952762
2,21.1,Hair colour changes,3,15952762
3,21.1,Hair disorder,3,15952762
4,21.1,Madarosis,3,15952762
0,21.1,Asthenia,6,15952768
1,21.1,Thrombosis,6,15952768
2,21.1,Fatigue,6,15952768
0,22.0,Death,5,15952774
0,22.0,Product use in unapproved indication,6,15952775
1,22.0,Death,5,15952775
0,21.1,Malaise,1,15952799
1,21.1,Abdominal pain upper,1,15952799
2,21.1,Chills,1,15952799
0,21.1,Rash pruritic,2,15952816
1,21.1,Purpura,2,15952816
0,21.1,Thrombocytopenia,1,15952838
1,21.1,Asthenia,1,15952838
2,21.1,Inappropriate schedule of product administration,6,15952838
3,21.1,Insomnia,6,15952838
4,21.1,Neuropathy peripheral,6,15952838
5,21.1,Platelet count decreased,1,15952838
0,21.1,Raynaud^s phenomenon,6,15952855
1,21.1,Bone marrow failure,6,15952855
2,21.1,Parkinson^s disease,6,15952855
3,21.1,Haematotoxicity,6,15952855
4,21.1,Syncope,6,15952855
0,21.1,Arteriosclerosis coronary artery,5,15952883
1,21.1,Atrial fibrillation,5,15952883
2,21.1,Malignant neoplasm progression,5,15952883
3,21.1,Thrombocytopenia,5,15952883
0,21.1,Pelvic pain,3,15952920
1,21.1,Diarrhoea,3,15952920
2,21.1,Vomiting,3,15952920
3,21.1,Asthenia,3,15952920
0,21.1,Carbohydrate antigen 125 increased,3,15952932
1,21.1,Drug ineffective,6,15952932
2,21.1,Malignant neoplasm progression,5,15952932
0,21.1,Diarrhoea,2,15953005
1,21.1,Weight decreased,2,15953005
2,21.1,Dehydration,2,15953005
3,21.1,Rash,2,15953005
4,21.1,Fatigue,2,15953005
0,21.1,Soft tissue sarcoma,5,15953006
0,21.1,Deep vein thrombosis,6,15953008
1,21.1,Pleuritic pain,2,15953008
2,21.1,Mobility decreased,6,15953008
3,21.1,Drug ineffective,6,15953008
4,21.1,Swelling,3,15953008
5,21.1,Nausea,3,15953008
6,21.1,Pulmonary embolism,6,15953008
7,21.1,Pain in extremity,3,15953008
8,21.1,Pruritus,3,15953008
9,21.1,Dyspnoea,2,15953008
0,22.0,Hot flush,3,15953016
1,22.0,Joint stiffness,3,15953016
2,22.0,Leukopenia,6,15953016
0,21.1,Interstitial lung disease,5,15953093
0,22.0,Hair texture abnormal,3,15953105
1,22.0,Hair colour changes,3,15953105
2,22.0,Hair disorder,3,15953105
3,22.0,Madarosis,3,15953105
4,22.0,Alopecia,3,15953105
0,22.0,White blood cell count decreased,1,15953107
1,22.0,Sinusitis,6,15953107
0,21.1,Death,5,15953149
1,21.1,Metastases to peritoneum,,15953149
2,21.1,Venoocclusive liver disease,,15953149
3,21.1,Off label use,,15953149
4,21.1,Palmar-plantar erythrodysaesthesia syndrome,,15953149
0,22.1,Cytopenia,6,15953164
1,22.1,Malaise,6,15953164
2,22.1,Discomfort,6,15953164
3,22.1,Hot flush,6,15953164
4,22.1,Pancytopenia,6,15953164
5,22.1,Night sweats,6,15953164
6,22.1,Joint stiffness,6,15953164
0,21.1,Infusion related reaction,4,15953244
0,21.1,Cardiac disorder,6,15953276
1,21.1,Atrial fibrillation,6,15953276
2,21.1,Urosepsis,1,15953276
0,22.0,Plasma cell myeloma,3,15953278
1,22.0,Acute leukaemia,6,15953278
2,22.0,Death,5,15953278
3,22.0,Influenza,1,15953278
0,22.1,Pain in extremity,1,15953295
1,22.1,Leukopenia,1,15953295
2,22.1,Neutropenia,1,15953295
3,22.1,Febrile neutropenia,1,15953295
4,22.1,Neutropenia,1,15953295
5,22.1,Fatigue,3,15953295
0,21.1,Death,5,15953316
0,21.1,Swollen tongue,1,15953318
1,21.1,Breast cancer,6,15953318
2,21.1,Reaction to preservatives,6,15953318
0,21.1,Platelet count decreased,6,15953326
1,21.1,Hepatic neoplasm,6,15953326
2,21.1,Dyspnoea,2,15953326
3,21.1,Neutropenia,6,15953326
4,21.1,Constipation,3,15953326
5,21.1,Arthralgia,6,15953326
6,21.1,Alopecia,3,15953326
7,21.1,Dyspepsia,2,15953326
0,22.0,Death,5,15953330
0,21.1,Death,5,15953339
0,21.1,Appendicitis,6,15953389
0,21.1,Drug resistance,6,15953404
1,21.1,Acquired gene mutation,6,15953404
0,21.1,Fatigue,3,15953463
1,21.1,Hepatic enzyme increased,3,15953463
2,21.1,Abdominal pain upper,3,15953463
0,22.0,Cardio-respiratory arrest,5,15953464
1,22.0,Urinary retention,6,15953464
2,22.0,Urinary tract infection,6,15953464
3,22.0,Staphylococcus test positive,6,15953464
4,22.0,Anaemia,6,15953464
5,22.0,Fluid retention,5,15953464
6,22.0,Oral candidiasis,6,15953464
7,22.0,Respiratory failure,5,15953464
8,22.0,Tachycardia,6,15953464
9,22.0,Malignant neoplasm progression,6,15953464
10,22.0,Product use in unapproved indication,6,15953464
11,22.0,Renal failure,5,15953464
0,21.1,Death,5,15953503
0,22.0,Pulmonary embolism,5,15953510
0,21.1,Hyperhidrosis,1,15953521
1,21.1,Product use in unapproved indication,6,15953521
2,21.1,Dysaesthesia,4,15953521
0,22.0,Septic shock,5,15953523
1,22.0,Stomatitis,5,15953523
2,22.0,Hepatic enzyme increased,5,15953523
3,22.0,Jaundice,5,15953523
4,22.0,Mental disorder,5,15953523
5,22.0,Dysphagia,5,15953523
6,22.0,Neoplasm progression,5,15953523
7,22.0,Pyrexia,5,15953523
8,22.0,Fatigue,5,15953523
0,22.1,Radiation pneumonitis,2,15953564
0,21.1,Death,5,15953578
0,21.1,Renal failure,3,15953629
0,21.1,Febrile neutropenia,3,15953676
0,21.1,Death,5,15953733
0,22.1,Arthralgia,3,15953743
1,22.1,Breast disorder,3,15953743
2,22.1,Carpal tunnel syndrome,3,15953743
3,22.1,Hypoaesthesia,3,15953743
4,22.1,Infusion related reaction,3,15953743
5,22.1,Radiculopathy,3,15953743
6,22.1,Joint swelling,3,15953743
7,22.1,Osteoarthritis,3,15953743
8,22.1,Synovitis,3,15953743
9,22.1,Blood pressure fluctuation,3,15953743
10,22.1,Blood pressure increased,3,15953743
11,22.1,Breast cancer,3,15953743
12,22.1,Drug ineffective,3,15953743
13,22.1,Gastrooesophageal reflux disease,3,15953743
14,22.1,Ill-defined disorder,3,15953743
15,22.1,Insomnia,3,15953743
16,22.1,Muscle spasms,3,15953743
17,22.1,Pain in extremity,3,15953743
18,22.1,Productive cough,3,15953743
19,22.1,Lymphoedema,3,15953743
20,22.1,Intentional product use issue,3,15953743
21,22.1,Bronchitis,3,15953743
22,22.1,Hypotension,3,15953743
23,22.1,Joint destruction,3,15953743
24,22.1,Anxiety,3,15953743
25,22.1,Atypical pneumonia,3,15953743
26,22.1,Breast cancer recurrent,3,15953743
27,22.1,Flushing,3,15953743
28,22.1,Pain,3,15953743
29,22.1,Peripheral swelling,3,15953743
30,22.1,Biliary colic,3,15953743
31,22.1,Diarrhoea,3,15953743
32,22.1,Joint range of motion decreased,3,15953743
33,22.1,Oxygen saturation decreased,3,15953743
34,22.1,Rheumatoid arthritis,3,15953743
35,22.1,Heart rate increased,3,15953743
36,22.1,Musculoskeletal pain,3,15953743
37,22.1,Oropharyngeal pain,3,15953743
38,22.1,Arthritis,3,15953743
39,22.1,Joint effusion,3,15953743
40,22.1,Lymphoma,3,15953743
41,22.1,Off label use,6,15953743
0,21.1,Death,5,15953744
0,21.1,Cutaneous lupus erythematosus,2,15953761
0,21.1,Acute myeloid leukaemia,6,15953764
1,21.1,Second primary malignancy,6,15953764
0,21.1,Essential thrombocythaemia,6,15953769
0,21.1,Death,5,15953782
0,21.1,Erythroleukaemia,3,15953806
1,21.1,Second primary malignancy,3,15953806
2,21.1,Pancytopenia,3,15953806
0,21.1,Syncope,1,15953823
0,22.0,Ovarian cancer,3,15953838
1,22.0,Carbohydrate antigen 125 increased,6,15953838
2,22.0,Abdominal pain upper,6,15953838
3,22.0,Ovarian cancer recurrent,3,15953838
4,22.0,Malignant neoplasm progression,3,15953838
5,22.0,Nausea,6,15953838
6,22.0,Decreased appetite,6,15953838
7,22.0,Hypophagia,6,15953838
8,22.0,Pain,1,15953838
9,22.0,Hypersensitivity,3,15953838
10,22.0,Weight decreased,6,15953838
11,22.0,Constipation,6,15953838
12,22.0,Feeling abnormal,6,15953838
13,22.0,Intestinal mass,6,15953838
14,22.0,Headache,3,15953838
15,22.0,Abdominal discomfort,6,15953838
16,22.0,Dyspepsia,6,15953838
0,21.1,Drug resistance,6,15953873
0,21.1,Malignant neoplasm progression,5,15953925
0,22.0,Acute kidney injury,2,15953930
1,22.0,Hypersensitivity vasculitis,6,15953930
0,21.1,Pulmonary fibrosis,3,15953944
0,21.1,Back pain,1,15953952
1,21.1,Hypersensitivity,1,15953952
0,21.1,Varices oesophageal,6,15953955
1,21.1,Hepatic enzyme increased,2,15953955
2,21.1,Hepatic cirrhosis,6,15953955
3,21.1,Hepatic steatosis,6,15953955
4,21.1,Non-alcoholic steatohepatitis,2,15953955
0,21.1,Subacute cutaneous lupus erythematosus,1,15953959
1,21.1,Palmar-plantar erythrodysaesthesia syndrome,6,15953959
0,21.1,Erythema,1,15953960
1,21.1,Nausea,1,15953960
2,21.1,Hypersensitivity,1,15953960
3,21.1,Dyspnoea,1,15953960
4,21.1,Abdominal pain,1,15953960
0,21.1,Death,5,15954005
0,22.1,Focal segmental glomerulosclerosis,6,15954064
1,22.1,Thrombotic microangiopathy,2,15954064
2,22.1,Cardiac failure,1,15954064
3,22.1,Nephrotic syndrome,2,15954064
0,21.1,Product dose omission,6,15954077
1,21.1,No adverse event,6,15954077
0,22.0,Product dose omission,6,15954189
1,22.0,Bladder cancer recurrent,3,15954189
2,22.0,Product availability issue,3,15954189
0,21.1,Scleroderma,3,15954195
0,22.0,Immune-mediated hepatitis,1,15954201
0,22.0,Drug hypersensitivity,5,15954257
1,22.0,Coma,5,15954257
2,22.0,Drug intolerance,5,15954257
3,22.0,White blood cell count decreased,6,15954257
0,21.1,Sepsis,6,15954290
1,21.1,Malignant neoplasm progression,6,15954290
2,21.1,Death,5,15954290
0,22.0,Bone marrow failure,6,15954296
0,21.1,Pulmonary embolism,1,15954310
0,21.1,Drug-induced liver injury,2,15954343
0,21.1,Bone marrow failure,6,15954346
1,21.1,Fatigue,6,15954346
2,21.1,Nausea,6,15954346
0,21.1,Thrombocytopenia,6,15954363
1,21.1,Coombs positive haemolytic anaemia,6,15954363
2,21.1,Coombs indirect test positive,6,15954363
3,21.1,Drug specific antibody,6,15954363
0,21.1,Sepsis,6,15954429
1,21.1,Spinal cord compression,6,15954429
2,21.1,Death,5,15954429
3,21.1,Malignant neoplasm progression,6,15954429
4,21.1,Mental status changes,6,15954429
5,21.1,Loss of consciousness,6,15954429
6,21.1,Asthenia,6,15954429
0,21.1,Neutropenia,6,15954453
1,21.1,Steroid diabetes,6,15954453
0,21.1,Osteoarthritis,2,15954470
0,21.1,Multiple organ dysfunction syndrome,5,15954480
1,21.1,Product use in unapproved indication,6,15954480
2,21.1,Malignant neoplasm progression,5,15954480
3,21.1,Adverse event,6,15954480
0,21.1,Anaemia,6,15954495
1,21.1,Malaise,3,15954495
0,21.1,Ischaemic stroke,1,15954503
0,21.1,Cerebrovascular accident,5,15954518
1,21.1,Metastases to central nervous system,5,15954518
2,21.1,Malignant neoplasm progression,5,15954518
0,21.1,Urosepsis,1,15954560
0,21.1,Disease progression,5,15954571
1,21.1,Neutropenia,1,15954571
2,21.1,Thrombocytopenia,1,15954571
0,21.1,Haemorrhage,1,15954580
